Novotech Publishes Whitepaper on Infectious Diseases Clinical Trials, Revealing Over 7,000 Trials Launched Worldwide
BOSTON, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, today published the latest 2023 global clinical trial environment whitepaper focused on infectious diseases.
- BOSTON, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, today published the latest 2023 global clinical trial environment whitepaper focused on infectious diseases.
- This helps to contribute to the advancement of knowledge of the clinical trials industry.
- The Infectious Diseases - Global Clinical Trial Environment (2018~2023) whitepaper offers a comprehensive assessment of the global clinical trial landscape.
- Other infectious diseases (16%), including protozoal infections, targeted a variety of agents that caused considerable morbidity, particularly in resource-limited areas.